Scalper1 News
Adamas Pharmaceuticals (ADMS) and Cerulean Pharma (CERU) launched IPOs Thursday, two of four biotechs expected to debut this week. Adamas priced at 16, the low end of its range. In late afternoon trading, the stock was near 15.30 on the stock market today. Adamas is developing new formulations of existing drugs for central nervous system disorders such as Parkinson’s and Alzheimer’s. It raised $48 million by offering 3 million shares. The Scalper1 News
Scalper1 News